Orion Biotechnology

About:

Orion Biotechnology is a clinical stage biotechnology company developing novel medical treatments.

Website: https://orionbiotechnology.com

Top Investors: Keiretsu Capital, Side Door Ventures, Keiretsu Forum, National Center for Research & Development, SevenTrainVentures

Description:

Orion Biotechnology is developing a pipeline of best-in-class biologic therapeutics based on Chemokine Analogue inhibitors, for the treatment of a broad range of serious unmet medical needs.

Total Funding Amount:

$14.2M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Ottawa, Ontario, Canada

Founded Date:

2011-01-01

Founders:

Rudolf Bom

Number of Employees:

11-50

Last Funding Date:

2024-07-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai